PP.29.30: HYPERTENSION IN FAMILY PRACTICE. (June 2015)

• Record Type: Journal Article
• Authors: Carvalho-Rodrigues, M.; Bronze, L.; Batista, M.; Madruga, M.; Peixeiro, A.; Castelo-Branco, M.
• Is Part Of: Journal of hypertension. Volume 33(2015)Supplement 1
• Publication Date: 2015-06
• Subjects: Hypertension -- Periodicals; Hypertension -- Periodicals; 616.132005
• DOI: 10.1097/01.hjh.0000468622.14186.dd
• Languages: English
• ISSNs: 1473-5598

Abstract

Abstract : Objective: To characterize, in a family practice setting, hypertension treated patients, namely their distribution by age and sex, therapy (single/associated), therapeutic control of hypertension and end organ damage. Design and method: From a population of 1631 patients in a family practice center, we reviewed the data of patients known to be hypertensive. Blood pressure recordings were obtained with the patient seated, using the oscillometric method, with at least two measurements separated from each other about 2 to 3 minutes; higher measurements were valued. The distributions for those patients, by age and sex, were found. We registered the therapeutic usage, valued the target organ damage and the control of blood pressure values. Results: The overall prevalence of hypertensive patients in the study population was 539 patients (539/1631 = 33.0 %), with a mean age of 68.8 ± 12.7 years, 339 female patients (339/539 = 62.8 %). Frequencies by age and sex are depicted below. The distribution of therapy was as follows: 1 (one) therapeutic class: 21.3%; 2 classes: 49.5%; 3 classes: 24.2%; 4 classes: 4.8% and 5 classes: 0.2%. In 13, 0 % of patients there was evidence of end organ damage; in 78.7 % there was no evidence of organ damage and in 8.3 % blood pressure was not controlled. Figure. No caption available. Conclusions: In this population of patients followed in primary care a prevalence of 33 % for hypertension treated patients was found. Medication included a combination of drugs in 80% of cases, most are women, and the most prevalent age distribution (for both genders) is between 60–80 years. Most patients had no target organ damage.